AdamNathanGoldfarbMD
Pathology • Charlottesville, VAHematopathology, Anatomic Pathology, Clinical Pathology
Professor of Pathology, University VA School of Medicine
Are you Dr. Goldfarb?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1215 Lee St
Charlottesville, VA 22908Phone+1 888-882-3990Fax+1 434-243-6499
Summary
- Dr. Adam Goldfarb, MD is a board certified pathologist in Charlottesville, Virginia. He is currently licensed to practice medicine in Virginia, Ohio, and Minnesota. He is a Professor of Pathology at University VA School of Medicine.
Education & Training
Tufts University School of MedicineClass of 1986
Certifications & Licensure
VA State Medical License 1998 - 2026
OH State Medical License 1993 - 1998
MN State Medical License 1987 - 1993
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Megakaryocyte centrosomal and Golgi structural perturbations in patients with primary myelofibrosis and withgermline mutation.Ifeyinwa E Obiorah, Debamita Kundu, Folashade Adekunle, Patcharin Pramoonjago, Katherine R Calvo
Leukemia & Lymphoma. 2025-04-01 - Chromatin structure and 3D architecture define the differential functions of PU.1 regulatory elements in blood cell lineages.Kevin Qiu, Duc C Vu, Leran Wang, Nicholas N Nguyen, Anna K Bookstaver
Epigenetics & Chromatin. 2024-11-01 - Transcriptional Regulation of the Lineage-Determining Genein Normal and Malignant Hematopoiesis: Current Understanding and Therapeutic Perspective.Emilia A Korczmar, Anna K Bookstaver, Ellison Ober, Adam N Goldfarb, Daniel G Tenen
Frontiers in Bioscience. 2024-05-06
Press Mentions
UVA Research May Improve Treatment of AnemiaApril 27th, 2021
Grant Support
- α-Synuclein Regulation of the Erythroid Iron Restriction ResponseUNIVERSITY OF VIRGINIA2024–2025
- Targeting Dyrk1a to Promote Donor-independent Platelet ProductionUNIVERSITY OF VIRGINIA2020–2025
- Dissection and Manipulation of the Cellular Response to Iron RestrictionUNIVERSITY OF VIRGINIA2008–2025
